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Abstract
Escherichia coli infection of the female reproductive tract is a significant cause of disease in
humans and animals, but simple animal models are lacking. Here we report that vaginal
inoculation of uropathogenic E. coli strains UTI89 and CFT073 in non-pregnant, estrogen-
treated mice resulted in robust colonization of the vagina and uterine horns, whereas titers
of the lab strain MG1655 were significantly lower. Non-estrogenized mice also became colo-
nized, but there was more variation in titers. A dose of 104 colony-forming units (CFU)
UTI89 was sufficient to result in colonization in all estrogenized mice, and we also observed
bacterial transfer between inoculated and uninoculated estrogenized cage mates. UTI89
infection led to inflammation and leukocyte infiltration into the uterine horns as evidenced by
tissue histology. Flow cytometry experiments revealed that neutrophil, monocyte and eosin-
ophil populations were significantly increased in infected uterine horns. This model is a sim-
ple way to study host-pathogen interactions in E. coli vaginal colonization and uterine
infection. There are immediate implications for investigators studying urinary tract infection
using mouse models, as few E. coli are required to achieve reproductive colonization, result-
ing in an additional, underappreciated mucosal reservoir.
Introduction
Bacterial infections of the female reproductive tract (FRT) are common and can carry serious
consequences. Escherichia coli is an opportunistic pathogen and frequent cause of human dis-
ease [1], including in the FRT [2]. Some women are vaginally colonized with E. coli in the
apparent absence of symptoms, with colonization rates ranging from ~5% [3, 4] to as high as
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~25% [5–7]. In some women, vaginal E. coli may trigger a painful inflammatory condition
termed aerobic vaginitis [3]. As well, E. coli residing in the vagina may be displaced into the
bladder to cause urinary tract infections (UTI). Women with a history of recurrent UTI are
more likely than healthy controls to harbor E. coli at the vaginal introitus [5, 8], and after sex-
ual intercourse (a common UTI trigger [9]), vaginal introital E. coli colonization increases
[10].
Ascending E. coli infection from the vagina to the upper FRT (i.e. uterine infection) is also a
significant cause of disease both in pregnant and non-pregnant women [11, 12]. During preg-
nancy, ascending E. coli infection can lead to a wide range of negative consequences for the
mother and child, such as neonatal or maternal sepsis, miscarriage and pre-term birth [2, 13–
15]. Strikingly, E. coli is considered the most common infectious organism associated with
stillbirth [13]. However, little is known about E. coli uterine infection outside of the context of
pregnancy.
Despite the many negative health consequences of E. coli FRT colonization, the pathogenic
cascade of E. coli in this niche is not well understood and only a few studies have used animals
models to examine this topic, for example in mice [16, 17] and monkeys [18]. We sought to
develop a simple mouse model of ascending E. coli FRT colonization after vaginal inoculation
with model E. coli strains, in order to better understand this infection and to characterize the
host immune response. We found that uropathogenic E. coli could readily colonize the mouse
vagina and did so especially well in mice treated with exogenous estrogen to halt the natural
estrous cycle. E. coli inoculation also resulted in ascending infection of the uterine horns,
where it elicited histological inflammation and immune cell infiltration. In contrast, a lab
strain of E. coli was highly attenuated in the FRT.
Methods
Ethics statement
All mouse experiments were conducted per the National Institutes of Health guidelines for the
housing and care of laboratory animals. All experiments were performed in accordance with
institutional regulations after review and approval by the Institutional Animal Care and Use
Committee at Washington University School of Medicine in St. Louis, MO (protocol numbers
20140114 and 20170081).
Bacterial strains
The E. coli isolates used were a kanamycin-resistant derivative (UTI89 attHK022::COMGFP)
of the human cystitis isolate UTI89 [19], a kanamycin resistant derivative (CFT073 HK::Kn) of
the human urosepsis isolate CFT073 [20], and a spectinomycin-resistant derivative (MG1655
attP::pPSSH10) of the lab strain MG1655 [21]. Strains were cultured statically in lysogeny
broth (LB) at 37˚C for two consecutive overnight passages, growth conditions commonly used
for uropathogenic E. coli to promote type 1 pilus expression [22].
Mouse infections
Female, five to seven weeks old, non-pregnant C57BL/6 mice from the Jackson Laboratory
were used for all experiments except the duration of the estrus phase after estrogenization,
which used C57BL/6 mice from both Jackson Laboratory and Envigo. For initial experiments,
mice were housed in static (non-ventilated) micro-isolator cages. At later stages of the
research, our animal facility moved to a new housing system where larger cages are docked in
HEPA-filtered ventilation racks that provide airflow control. In the three days prior to
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inoculation, mice received two doses of 0.5 mg β-estradiol 17-valerate (Sigma, St. Louis, MO,
USA) in 100 μl filter-sterilized sesame oil (Fisher, NH, USA) via intraperitoneal injection to
synchronize the mice in estrus [23]. At the time of infection, 104 colony-forming units (CFU)
of bacteria were resuspended in phosphate-buffered saline (PBS) and inoculated into the vagi-
nas in 20 μl volumes. For mock infections (controls for histology and flow cytometry experi-
ments), mice were estrogenized, then inoculated with 20 μl PBS and housed in cages separate
from infected mice (except during transmission experiments where mock-infected mice were
co-housed with infected mice). At experimental end points, animals were humanely eutha-
nized by isoflurane inhalation followed by cervical dislocation. To enumerate bacterial CFUs,
vaginal washes were collected using PBS as previously described [23], serially diluted and
plated on MacConkey agar containing 25 μg/ml kanamycin or 20 μg/ml spectinomycin. At
experimental end points, mice were humanely sacrificed and vaginas and uterine horns were
harvested, weighed, homogenized and serially diluted in PBS, then plated on MacConkey agar
containing 25 μg/ml kanamycin or 20 μg/ml spectinomycin for CFU enumeration.
Observations of the estrous cycle
To monitor the estrous cycle when testing the duration of estradiol treatment, vaginal washes
were collected after 1, 2, 3, 6, 8, 10, 13, 15, 17, 20, 22, 25, 27, 29 and 31 days (a total of 15 times
over the 31-day experiment) and wet mounts were prepared and observed at 20x magnifica-
tion on a Nikon (Tokyo, Japan) Diaphot inverted microscope. Images were acquired using an
AmScope (CA, USA) microscope digital camera (MU300, 3.1 MP). Representative images
were assessed by four independent investigators and the consensus date on which each mouse
came out of estrus was plotted; at least three out of four investigators agreed for each mouse.
Vaginal wash scoring
To assess immune cell infiltration into vaginal wash fluid, at indicated time points, 5 μl of vagi-
nal wash was smeared onto a slide and stained with the Hema 3 staining kit (Fisher, NH, USA)
after air drying. Immune cells and epithelial morphology were assessed on an Olympus
(Tokyo, Japan) BX61 bright field microscope.
Histopathology
The reproductive tract (vagina, cervix, and uterine horns) was harvested as an intact structure,
fixed overnight in 10% neutral-buffered formalin (Fisher, NH, USA), paraffin-embedded and
sectioned. Slides were stained with hematoxylin and eosin, then imaged with an Olympus
(Tokyo, Japan) BX61 bright field microscope. An observer blinded to the infection status of
the samples scored the level of polymorphonuclear cells in the tissue based on the following
rubric: 0 –absent, 1 –minimal, 2 –moderate, 3 –profound, 4 –severe (including immune cells
crossing the epithelium into the lumen).
Flow cytometry
Replicates were conducted with five mice per group (1–2 mock-infected with PBS and 3–4 E.
coli UTI89-infected). At 12 days post-infection, mice were humanely euthanized without per-
fusion and the vagina, cervix and uterine horns were collected and kept on ice in 1 ml RPMI
buffer containing 1% fetal bovine serum, 1% penicillin/streptomycin, and 50 μM 2-mercap-
toethanol. Single cell suspensions were generated and flow cytometry was performed as previ-
ously described [24]. The following antibodies were used for this study: TruStain fcX
(BioLegend, CA, USA, clone 93), Siglec-F (BD Pharmingen, NJ, USA, clone E50-2440), LyG6
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(BioLegend, clone 1A8), CD11b (BioLegend, clone M1/70), CD11c (BioLegend, clone N418),
Ly6C (BioLegend, clone HK1.4), F4/80 (BioLegend, clone BM8), and I-A/I-E (BioLegend,
clone M5/114.15.2). CountBright beads (Invitrogen, CA, USA) were added to samples prior to
acquisition to determine cell counts.
Statistical analysis
All relevant data, including individual data points (not just central tendency and variance mea-
sures), are presented within the paper and supplementary figures. Statistics were performed in
GraphPad (CA, USA) Prism v7.01. A two-tailed Fisher’s exact test was used to test for signifi-
cant differences in the incidence of uterine horn colonization and the presence of uterine horn
leukocytes. Spearman’s rank correlation coefficient was used to test for significant associations
among titers in vaginal washes, vaginal and uterine horn tissue, and uterine histology. For
other data, comparisons of three or more groups were performed with the Kruskal-Wallis test
followed by Dunn’s correction. Pairwise comparisons were performed with a two-tailed
Mann-Whitney U test. P�0.05 was considered statistically significant. For histology scoring,
investigators were blinded to the infection status of the animals.
Results
In this study, we sought to establish a simple mouse model of E. coli infection of the female
reproductive tract. In C57BL/6 mice, after vaginal inoculation with 104 colony-forming units
(CFU) of the clinical E. coli isolate UTI89, E. coli titers in vaginal washes rose and fell over time
(Fig 1 and S1 Fig). Of 17 mice tested in two replicates, two had stably high titers over time,
three never had detectable titers at any time point, and 12 had variable titers that were some-
times high, sometimes low and sometimes undetectable. The percentage of mice with any
detectable titer was greatest at one day post-infection (dpi), with titers detected in 14 mice
(76%), and decreased over time.
We reasoned that the heterogeneity we observed in E. coli vaginal colonization in Fig 1
could be the result of mice being in different phases of the estrous cycle. Indeed, established
mouse models of vaginal bacterial infection have circumvented this issue by arresting the
estrous cycle with β-estradiol 17-valerate [23, 25], which keeps mice in pseudo-estrus, marked
by an abundance of cornified epithelial cells, few nucleated epithelial cells, and an absence of
leukocytes in vaginal washes [26]. These prior studies did not report how long β-estradiol
treatment is effective, so we first assessed the duration of the estrus phase in estrogenized mice
for one month after treatment. C57BL/6 mice from Jackson or Envigo were given two doses of
0.5 mg β-estradiol 17-valerate by intraperitoneal injection and vaginal washes were collected
over time and scored according to the criteria in [27] (Fig 2). Interestingly, we observed a ven-
dor effect: three of five Envigo mice exited estrus by 13 days post-treatment, and by 31 days,
only one mouse was still in estrus. In contrast, only one Jackson mouse exited estrus (by day
13) during the 31-day period. Thus, for subsequent experiments we used only estrogenized
C57BL/6J (Jackson) mice (Fig 3A).
We found that 24 hours after vaginal inoculation with 104 CFU of UTI89, estrogenized
mice had vaginal titers clustered around 105 CFU/mg tissue, with a wider spread of uterine
horn titers ranging from undetectable to 105 CFU/mg (Fig 3B). We wondered whether coloni-
zation would be stable over time in estrogenized mice. Indeed, we detected consistently high
vaginal wash titers over the course of 12 days (Fig 3C), between 107 and 108 CFU/ml. Some
mice remained colonized for three weeks or more (Fig 3D), in keeping with the long duration
of estrus in estrogenized Jackson mice.
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The vagina is considered a reservoir for uropathogenic E. coli, which may ascend through
the urethra to establish urinary tract infections [28]. Thus, we compared FRT infection with
the well-characterized urinary tract infection clinical isolates UTI89 and CFT073 versus the
lab strain MG1655, in each case using a 104 inoculum. Bacterial titers were enumerated at 12
dpi (Fig 3E–3G). Both UTI89 and CFT073 colonized the FRT robustly, with median titers of
~108 CFU/ml vaginal wash, ~105 CFU/mg vaginal tissue, and ~103 to ~104 CFU/mg uterine
horn tissue; despite high bacterial titers, mice did not appear sick (no hunching, hair loss, leth-
argy, etc.). In contrast, MG1655 titers were statistically significantly lower throughout the
FRT. Strikingly, 4 of 10 mice infected with MG1655 had no recoverable uterine horn CFUs,
whereas bacteria were recovered from the uterine horns of all mice infected with UTI89
(P< 0.05, Fisher’s exact test) or CFT073.
To test whether E. coli uterine infection reflects the extent to which the vagina becomes
robustly colonized, we looked for significant correlations among titers of UTI89, CFT073 and
MG1655 in vaginal washes, vaginal tissue and uterine horn tissue with Spearman correlation
Fig 1. Vaginal E. coli titers wax and wane in mice not treated with exogenous estrogen. Seventeen non-pregnant
female C57BL/6 Jackson mice were vaginally inoculated with E. coli strain UTI89, and vaginal washes were collected to
monitor infection status over 12 days. Each point shows an individual mouse, with lines connecting the titers of a given
mouse from one time point to the next. The percentage of mice with any detectable titer is shown in the box at the top
of the graph. Data are combined from two independent experiments and zeros are plotted at the limit of detection.
These experiments were conducted with static (non-ventilated) micro-isolator cages.
https://doi.org/10.1371/journal.pone.0219941.g001
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analysis. When data for all three E. coli strains were combined, titers in the vaginal washes
were significantly correlated with titers found in the vaginal homogenates (Fig 4A, first panel,
P< 0.05), as expected. As well, titers in the uterine horn homogenates were significantly corre-
lated with both vaginal titers (Fig 4B, first panel, P< 0.05) and vaginal wash titers (Fig 4C, first
panel, P< 0.0001), suggesting that indeed, ascending uterine horn infection in this model may
directly reflect the robustness of vaginal colonization. However, when we tested correlations
Fig 2. After exogenous estrogen treatment, some C57BL/6J mice stay in the estrus phase for several weeks. C57BL/6 mice from Jackson or Envigo were given two
doses of β-estradiol 17-valerate 72 hours apart and followed for one month. (A) Vaginal (PBS) washes were collected at the indicated 15 time points over 31 days and the
stage of the estrous cycle was determined by wet mount microscopy according to the criteria in [27]. Data are from one experiment with n = 5 mice per group. (B)
Shown are wet mount images at 20x magnification, taken at the indicated days post-estrogenization, from one representative Jackson mouse that did not come out of
estrus during the experiment (top row) and one representative Envigo mouse that came out of estrus on day 13 (bottom row). Estrus is defined as an abundance of
cornified epithelial cells in washes (examples marked with � in the first column); as mice leave estrus these are replaced by more rounded epithelial cells (examples
marked with # in the third column) and leukocytes (examples marked with arrows in the third column). These experiments were conducted with static (non-ventilated)
micro-isolator cages.
https://doi.org/10.1371/journal.pone.0219941.g002
Escherichia coli uterine infection in mice
PLOS ONE | https://doi.org/10.1371/journal.pone.0219941 July 22, 2019 6 / 18
for each strain individually, we found that UTI89 titers were not significantly correlated in any
comparison (Fig 4A–4C, second panels). CFT073 titers were significantly correlated or
trended toward significance for all comparisons (Fig 4A–4C, third panels), and only MG1655
vaginal wash and uterine horn titers were significantly correlated (Fig 4A–4C, fourth panels).
These data suggest that bacterial strain-specific differences may impact the association between
vaginal and uterine colonization in this model.
Fig 3. Clinical uropathogenic E. coli isolates robustly colonize the female reproductive tract of estrogenized mice. (A) Mouse vaginal E. coli infection model. Non-
pregnant female C57BL/6 Jackson mice were given two doses of β-estradiol 17-valerate (E2) and vaginally inoculated with E. coli strains, then followed for 12 days.
Vaginal washes were collected to monitor infection status. (B through D) Mice were infected with UTI89. Bacterial titers were enumerated in vaginal and uterine horn
tissues after 24 hours (B) and in vaginal washes in 12 day infections (C) and a longer-term (26 day) infection (D). (E through G) Mice were infected with the E. coli
strains UTI89 (n = 14), CFT073 (n = 10) or MG1655 (n = 10) for 12 days. Bacterial titers were enumerated in vaginal washes (E), vaginal homogenates (F) and uterine
horn (UH) homogenates (G). Data are combined from two or more independent experiments except for (B and D); zeros are plotted at the limit of detection and bars
indicate median values. �� P< 0.01, ��� P< 0.001, Kruskal-Wallis test with Dunn’s correction. hpi, hours post-infection; dpi, days post-infection. These experiments
were conducted with static (non-ventilated) micro-isolator cages.
https://doi.org/10.1371/journal.pone.0219941.g003
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We considered whether the acts of vaginal inoculation and/or washing may have intro-
duced E. coli into the uterine horns. However, E. coli was not detectable in the uterine horns of
mice sacrificed immediately after vaginal inoculation of 104 CFU of UTI89 (Fig 5A). As well,
similar levels of UTI89 were recovered from the uterine horns at seven dpi in all (four of four)
mice that were never vaginally washed following inoculation (Fig 5B, compare to Fig 3G).
Finally, we observed spontaneous E. coli transmission from infected to mock-infected (PBS-
inoculated) cage mates. In these experiments, three UTI89-infected mice were co-housed with
two mock-infected mice (all estrogenized). At 12 dpi, vaginal and uterine horn titers were enu-
merated. Two experiments of this kind were performed with different housing conditions (see
Methods). In both experiments, kanamycin-resistant UTI89 could be recovered from both
vaginal and uterine horn homogenates of co-housed, mock-infected animals (Fig 5C). Taken
together these findings demonstrate that in estrogenized mice, ascending infection of the uter-
ine horns can occur with low-level vaginal inoculation of E. coli or following transmission
between cage mates, and does not require investigator intervention.
During the normal estrous cycle, white blood cells infiltrate the vaginal lumen after ovulation
(metestrus and diestrus); keeping mice in a pseudo-estrus phase via administration of β-estradiol
17-valerate prevents this influx of white blood cells. Here, light microscopy of Hema 3-stained
Fig 4. Uterine horn titers are significantly positively correlated with titers in the vagina and vaginal washes. The E. coli titers from all mice shown in Fig 3E–3G
were assessed by Spearman correlations comparing vaginal washes vs. vaginal homogenates (A), vaginal homogenates vs. uterine horn homogenates (B), and vaginal
washes vs. uterine horn homogenates (C). The first column shows all bacterial strains (UTI89, CFT073, and MG1655) combined, and the second, third and fourth
columns show UTI89, CFT073 and MG1655 individually. The Spearman correlation P value is indicated in the top right of each graph. Data are combined from two or
more independent experiments and zeros are plotted at the limit of detection. These data come from experiments conducted with Jackson mice housed in static (non-
ventilated) micro-isolator cages.
https://doi.org/10.1371/journal.pone.0219941.g004
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smears of vaginal washes collected at one, seven and 12 days post-UTI89 infection revealed white
blood cells and parabasal epithelial cells (Fig 6A). A blinded assessment revealed significantly
more white blood cells in infected mice compared to mock-infected (PBS-inoculated) controls,
and higher numbers of parabasal cells, though not statistically significant (P = 0.11) (Fig 6B).
Since estrogenization suppresses vaginal leukocyte infiltration, we sought to further charac-
terize the source of the inflammatory infiltrates in the FRT in response to E. coli infection. We
first performed blinded scoring of tissue sections collected at 12 dpi from infected and mock-
infected (PBS-inoculated) mice. We observed no evidence of vaginal histological inflammation
(inflammatory score of zero) in three of three mock-infected mice and ten of 11 UTI89-in-
fected mice (with one mouse having a score of two, defined by moderate infiltration of poly-
morphonuclear cells) (Fig 7A and 7B), suggesting that the white blood cells present in vaginal
washes were not vaginal in origin. In the uterine horns, we observed polymorphonuclear leu-
kocytes (PMNs) in the tissue of one of eight mock-infected mice, and in the tissue and/or
lumen of 11 of 13 UTI89-infected mice (P< 0.01, Fisher’s exact test) (Fig 7C and 7D). PMNs
were also present in the uterine horn tissue and/or lumen in six of 11 MG1655-infected mice
(Fig 7C and 7D), though only two of 11 had the highest score (defined by profound tissue
inflammation plus immune cells crossing the epithelium into the lumen) compared to six of
13 UTI89-infected mice. Comparable levels of inflammation were seen in each horn of a given
mouse. Because both horns were used for histology, bacterial titers of the uterine horns are not
known for these experiments; however, vaginal washes were collected. UTI89 vaginal wash
titers were not significantly correlated with uterine horn histology scores (Fig 7E); although
there was a wide spread of uterine histology scores, UTI89 vaginal wash titers were all clustered
between 107 and 108 CFU/ml vaginal wash. In contrast, MG1655 vaginal wash titers and
Fig 5. Ascension to the upper FRT is not due to techniques employed during vaginal inoculation or washing, and E. coli in the FRT can be
spontaneously transmitted among estrogenized cage mates. Shown are bacterial titers in the vagina and uterine horns. (A) Estrogenized mice were
vaginally inoculated with 104 CFU of UTI89 and immediately sacrificed. (B) Estrogenized mice were vaginally inoculated with 104 CFU of UTI89 and
sacrificed at seven dpi without collecting vaginal washes. (C) In two experiments (the first shown in black and the second in grey), a cage of five mice were
estrogenized. Two were mock-infected with PBS and three were infected with 104 CFU of UTI89. At 12 dpi, UTI89 was detected in all infected mice, and was
also detected in the vagina of four out of four mock-infected cage mates and in the uterine horns of three out of four mock-infected cage mates. All mice came
from the Jackson Laboratory; experiments from panels A and B and replicate one in panel C were performed with static (non-ventilated) microisolator cages,
and replicate two in panel C was performed with HEPA-filtered cages with airflow control. Zeros are plotted at the limit of detection and bars indicate median
values.
https://doi.org/10.1371/journal.pone.0219941.g005
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uterine histology scores suggest a different relationship in which higher bacterial numbers
were seen alongside higher uterine inflammatory scores, but a positive correlation did not
quite reach statistical significance (P = 0.0512) (Fig 7F).
To further characterize immune cell infiltration into the infected FRT, we performed flow
cytometry to enumerate neutrophils, monocytes, macrophages, and eosinophils at 12 dpi in
UTI89-infected mice relative to mock-infected (PBS-inoculated) mice (see S2 Fig for our gat-
ing strategy). In accordance with tissue histology, we did not observe higher levels of any of
the above cell types in infected vaginal tissue compared to the mock-infected control group
(Fig 8A). However, infected uterine tissues had significantly higher numbers of neutrophils,
monocytes and eosinophils compared to mock-infected uterine horns (Fig 8B). Evaluation of
these immune cells in cervical tissue did not reveal differences in the numbers of these
immune cell subsets between mock-infected and E. coli-infected animals, suggesting that the
cervix is not the source of these immune cells (S3 Fig). Thus, ascending E. coli infection of the
FRT elicits a strong uterine inflammatory response and severe immunopathology in the uter-
ine horns, despite potential immunosuppressive effects of exogenous estrogen treatment.
Discussion
E. coli is a relatively common pathogen of the FRT, and ascending E. coli infection causes a
variety of negative health outcomes [13, 29]. Here we describe a model of ascending E. coli
Fig 6. Vaginal washes from infected mice contain white blood cells. Vaginal washes from estrogenized Jackson mice
were collected at the indicated time points and examined by light microscopy. (A) White blood cells (examples
indicated with circles) and exfoliated vaginal epithelial cells (examples indicated with arrows) were observed in washes.
Scale bars = 100 μm. (B) Vaginal washes from UTI89-infected and mock-infected (PBS-inoculated) mice were scored
for the presence of parabasal cells and white blood cells (WBCs) in a blinded fashion. � P< 0.05, Mann-Whitney U
test. These experiments were conducted with static (non-ventilated) micro-isolator cages.
https://doi.org/10.1371/journal.pone.0219941.g006
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infection in non-pregnant mice. Vaginal inoculation with low doses of the clinical uropatho-
genic E. coli isolates UTI89 and CFT073 resulted in robust colonization of the FRT over 12
days, while titers of the lab strain MG1655 were significantly lower, especially in the uterine
horns. UTI89 infection elicited leukocyte accumulation in vaginal washes, as well as significant
uterine inflammation observed by histological analysis. Flow cytometry revealed significantly
more neutrophils, monocytes and eosinophils in infected vs. mock-infected uterine horns.
Thus, ascending E. coli FRT infection and resulting uterine inflammation can be modeled in
mice without surgical inoculation.
It is important to note that most of the experiments presented here employed treatment
with exogenous estrogen (so-called “estrogenization”) to keep mice in pseudo-estrus and
Fig 7. E. coli infection elicits inflammation in the uterine horns but not the vagina. Estrogenized Jackson mice were infected with the E. coli strains UTI89 or
MG1655, or mock-infected with PBS. After 12 days, inflammation was assessed in vaginal and uterine horn tissues by a blinded assessment of hematoxylin and
eosin-stained tissue sections. (A) Representative images of vaginal tissue from mock-infected vs. UTI89-infected mice. Scale bars, 100 μm. (B) Blinded scoring of
vaginal inflammation, where 0 = absent (normal tissue with no immune infiltrate in epithelium), 1 = minimal, 2 = moderate, 3 = profound and 4 = severe
(profound tissue inflammation plus immune cells crossing the epithelium into the lumen). (C) Representative images of uterine horn tissue from mock-infected
vs. UTI89 or MG1655-infected mice. Scale bars on the top row are 100 μm; squares indicate regions shown at higher magnification on the bottom row, with scale
bars indicating 20 μm. (D) Blinded scoring of uterine horn inflammation, using the same scoring criteria from panel B. �� P< 0.01, Kruskal-Wallis test with
Dunn’s correction. (E and F) Spearman’s correlation was used to compare vaginal wash titers collected at the time of sacrifice to the uterine horn histology scores
shown in panel D for mice infected with UTI89 (E) or MG1655 (F). Data are from four independent experiments conducted in both static (non-ventilated) micro-
isolator cages and HEPA-filtered cages with airflow control, with similar results between conditions.
https://doi.org/10.1371/journal.pone.0219941.g007
Fig 8. Flow cytometry demonstrates increased neutrophil, monocyte and eosinophil infiltration into the uterine horns upon E. coli infection. Flow
cytometry was performed on vaginal (VG, panel A) and uterine horn (UH, panel B) single cell suspensions from mock-infected (PBS-inoculated) or
UTI89-infected Jackson mice. The gating strategy used was: Siglec-F-, Ly6G+ cells were considered neutrophils; Siglec-F-, Ly6G-, CD11b+, CD11c-, Ly6C+
cells were considered monocytes; Siglec-F-, Ly6G-, CD11b+, CD11c-, Ly6C-, F4/80+ cells were considered macrophages; and Siglec-F+ cells were considered
eosinophils. � P< 0.05, �� P< 0.01, Mann-Whitney U test. Data are combined from two or more independent experiments; data points represent actual
values for each individual mouse and bars indicate median values. These experiments were conducted with static (non-ventilated) micro-isolator cages.
https://doi.org/10.1371/journal.pone.0219941.g008
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prevent normal cycling. Although most non-estrogenized mice did exhibit E. coli titers in vagi-
nal washes to varying extents, consistently high titers only occurred in estrogenized mice.
Many mouse models of vaginal infection require the arrest of the estrous cycle for robust infec-
tion: either with medroxyprogesterone acetate (Depo-Provera) to keep mice in diestrus for
viral infections [30, 31], or by estrogenization with β-estradiol 17-valerate (E2) to keep mice in
estrus for bacterial infections [23, 25]. The estrus phase comprises abundant cornified epithe-
lial cells and an absence of leukocytes in vaginal washes [26], conditions which may favor E.
coli colonization. Estrogenization prevents the normal influx of leukocytes into the vagina that
occurs during diestrus, and has other immunosuppressive effects [32]. The fluctuating vaginal
E. coli levels that we observed in non-estrogenized mice may be due to normal leukocyte infil-
tration during the estrous cycle. As well, the apparent lack of vaginal inflammation in estro-
genized mice at 12 dpi, despite sustained, robust E. coli colonization, may be attributable to
local immunosuppression due to estrogenization. Nonetheless, we observed abundant leuko-
cytes in vaginal washes from infected, estrogenized mice as early as one dpi. Tissue histology
and flow cytometry at 12 dpi suggested that the uterine horns, not the vagina, were the source
of the inflammatory cells. Thus, the immunosuppressive effects of estrogen can be overcome,
at least in the uterine horns. We note that uterine inflammation does not appear to be a general
consequence of Gram-negative bacterial infection in estrogenized mice, as high-titer Prevotella
bivia ascending infection resulted in neither localized (uterine) nor systemic inflammation by
histological analysis and/or flow cytometry at two and seven dpi [33]. Our finding of uterine
inflammation upon E. coli infection in mice is consistent with a previous report wherein surgi-
cal infusion of E. coli directly into the uteri of non-pregnant C57BL/6 mice caused severe
inflammation [34], which was attributed to TLR4-driven signaling in both epithelial and stro-
mal cells [35]. Our non-surgical model serves as a straightforward means of testing candidate
virulence factors or vaccine antigens in the context of severe innate immune cell infiltration,
which could yield findings relevant to E. coli infections at other body sites, such as the gut,
bladder, and kidneys–or in the neonatal lung, blood and brain.
Our finding that MG1655 titers in the FRT were statistically significantly lower than titers
of the uropathogenic strains UTI89 and CFT073 echoes findings in pregnant mice that a patho-
genic E. coli strain caused more robust ascending uterine infection than the lab strain MG1655
and caused significantly greater upregulation of the neutrophil chemoattractants Cxcl1 and
Cxcl2 in uterine tissue, although in that study titers were not determined [17]. Here we observed
that for the two robust colonizers, UTI89 and CFT073, E. coli titers in vaginal washes and vagi-
nal tissue (at 12 dpi) were relatively tightly clustered around ~108 CFU/ml vaginal wash and
~105 CFU/mg vaginal tissue, respectively. In contrast, uterine horn titers had a much wider
range of ~102 to ~106 CFU/mg tissue. For both CFT073 and MG1655, uterine horn titers were
significantly correlated with vaginal wash titers, and for MG1655, uterine horn histology scores
were also significantly correlated with vaginal wash titers, suggesting that for these two strains,
the ascending infection was a direct result of robustness of the vaginal infection. UTI89 did not
display significant correlations between vaginal and uterine horn titers or uterine horn histology
scores, and therefore it remains unknown why UTI89 uterine infection was so robust in some
animals and more muted in others. Because our histology and flow cytometry experiments used
the entire organ, the uterine horn titers are not known for these experiments and cannot be
directly tested for correlations with immune cell infiltrates. Future studies should test whether
the degree of uterine inflammation is correlated (positively or negatively) with UTI89 uterine
horn titers, to better understand the pathophysiology of ascending E. coli uterine infection.
Although UTI89 and CFT073 are both uropathogenic E. coli strains belonging to the B2
clade, and are more similar to one another than they are to MG1655, they are genetically dis-
tinct strains and some key virulence factors are only found in UTI89 [36]; for example, UTI89
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encodes the cytotoxic necrotizing factor CNF1, which is not found in CFT073 or MG1655 and
which could therefore impact UTI89 colonization specifically. Others have reported heteroge-
neity in the virulence factor profiles of E. coli isolated from the FRT of pregnant and non-preg-
nant women [2, 37, 38]. However, little is known about the specific bacterial factors that may
mediate colonization. We propose our model as a straightforward means of testing candidate
antigens for their role in FRT infection and inflammation.
A few studies examining the beneficial role of Lactobacillus species as vaginal probiotics
have tested the ability of Lactobacillus to prevent or clear vaginal E. coli infection in mice [39,
40] and cynomolgus monkeys [41]. Our study highlights the importance of using multiple E.
coli strains for such experiments, as we showed that strains differ in their ability to colonize the
vagina. We note that mice harbor a vaginal microbiome that is distinct from the Lactobacillus-
dominated “healthy” microbiome seen in women [42]. In the present study, we did not assess
whether or how the vaginal microbiota may have changed in response to estrogenization or E.
coli infection, and we did not look for any bacteria other than E. coli in the uterine horns.
Thus, whether and to what extent E. coli infection may disrupt existing microbial communi-
ties–or conversely, how the composition of the endogenous microbiome may influence sus-
ceptibility to ascending infection–remain open questions.
Mouse models of E. coli bladder infection typically use a 107 or 108 CFU dose (for example,
[22]), while here we found that a vaginal dose of 104 CFU was sufficient to colonize all estro-
genized animals. The observation that infected mice could apparently transmit E. coli to co-
housed, uninfected mice provides further support for our conclusion that E. coli can very read-
ily colonize the estrogenized FRT. Here we note that the second replicate of this experiment
was performed after our mouse facility changed to a new housing system (see Methods).
Although the overall conclusion of these experiments, that E. coli can be transferred between
cage mates, held true, we did note lower overall levels of E. coli in uninfected cage mates fol-
lowing the change in housing. Whether these differences are due to aspects of the inoculation,
such as trauma, fluid flow, anesthesia etc., and/or factors relating to the housing, such as bed-
ding that is more dry and harboring fewer bacteria, remains to be elucidated.
Together with our observations that uropathogenic E. coli was an especially capable vaginal
colonizer and that even non-estrogenized animals can carry E. coli vaginally for long periods,
these findings suggest that urinary tract infection models may also result in significant E. coli
FRT reservoirs, a phenomenon that may vary in intensity depending on housing conditions
and other factors. There are multiple reported mouse models of chronic and/or recurrent blad-
der infection reported in the literature (for example, [22, 43]). The likely outcome that E. coli
in urine could result in vaginal colonization and ascending uterine infection in these models
requires new consideration that an FRT reservoir may contribute to certain aspects of bladder
pathophysiology in mice, as it does in humans. Importantly, elegant experiments previously
showed that experimental bladder infection with UTI89 in pregnant mice caused intrauterine
growth restriction (low gestational and birth weights), due to inflammation-mediated “cross-
talk” between organ systems [44]. Whether cross-talk may be bi-directional–that is to say,
whether uterine inflammation caused by ascending uterine E. coli infection could also affect
UTI outcomes–is an open question. Another potential technical consideration is that “clean
catch” procedures for urine collection do not exist for mouse experiments and thus vaginal
colonization could potentially contribute to E. coli titers detected in urine.
A mouse surgical infection model was previously used to study the E. coli factors necessary
for uterine colonization [34, 35]. Our work shows that uterine E. coli infection can be studied
without surgery, making future studies less technically challenging. As well, given the impor-
tance of E. coli uterine infection in causing pregnancy complications, a few studies have inves-
tigated vaginal E. coli inoculation in pregnant rodents [16, 17, 45], though without assessing
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bacterial titers, histology or immune cell infiltration. Performing vaginal infections in the con-
text of pregnancy is essential, but also technically demanding and resource-intensive. Our
model provides a less technically complicated, less invasive, and more natural means to investi-
gate host-pathogen interactions in ascending E. coli uterine infections. We hope that this
model may be used to discover bacterial virulence factors promoting ascension and inflamma-
tion, and to test therapeutic interventions. Those discoveries can then be validated in preg-
nancy models, which may lead to improved health outcomes.
Supporting information
S1 Fig. Vaginal E. coli titers wax and wane in mice not treated with exogenous estrogen.
Seventeen non-pregnant female Jackson C57BL/6 mice were vaginally inoculated with E. coli
strain UTI89, and vaginal washes were collected to monitor infection status over 12 days. Each
panel corresponds to one replicate of the experiment. Each point shows an individual mouse,
with lines connecting the titers of a given mouse from one time point to the next. The percent-
age of mice with any detectable titer is shown in the box at the top of the graph. Zeros are plot-
ted at the limit of detection. These experiments were conducted with static (non-ventilated)
micro-isolator cages.
(TIF)
S2 Fig. Gating strategy used for flow cytometry experiments. Shown is a representative
UTI89-infected mouse at 12 dpi. These experiments were conducted with Jackson mice
housed in static (non-ventilated) micro-isolator cages.
(TIF)
S3 Fig. Flow cytometry did not show significantly elevated immune populations in the cer-
vix upon E. coli infection. Flow cytometry was performed on cervical single cell suspensions
from mock-infected (PBS-inoculated) or UTI89-infected Jackson mice. The gating strategy
used was: Siglec-F-, Ly6G+ cells were considered neutrophils; Siglec-F-, Ly6G-, CD11b+,
CD11c-, Ly6C+ cells were considered monocytes; Siglec-F-, Ly6G-, CD11b+, CD11c-, Ly6C-,
F4/80+ cells were considered macrophages; and Siglec-F+ cells were considered eosinophils.
No cell populations were statistically significantly different between groups. Data are com-
bined from two or more independent experiments; data points represent actual values for each
individual mouse and bars indicate median values. These experiments were conducted with
static (non-ventilated) micro-isolator cages. CX, cervix.
(TIF)
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